Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys322
Sells6529
Buy $$14.24B
Sell $$8.99B
Ratio1.58:1
% Change vs. Prior
Ratio +4210.4%Value +143.4%
Healthcare
Buys517
Sells4752
Buy $$739.69M
Sell $$14.16B
Ratio1:19.14
% Change vs. Prior
Ratio +122.7%Value -83.5%
Utilities
Buys36
Sells200
Buy $$4.77M
Sell $$7.20B
Ratio1:1508.60
% Change vs. Prior
Ratio -99.9%Value +3043.1%
Industrials
Buys328
Sells2421
Buy $$110.61M
Sell $$6.92B
Ratio1:62.53
% Change vs. Prior
Ratio -69.6%Value +41.4%
Energy
Buys191
Sells879
Buy $$90.05M
Sell $$5.50B
Ratio1:61.03
% Change vs. Prior
Ratio -79.7%Value +134.6%
Financial Services
Buys1734
Sells2631
Buy $$813.43M
Sell $$4.40B
Ratio1:5.40
% Change vs. Prior
Ratio +26.7%Value -5.6%
Consumer Cyclical
Buys267
Sells1893
Buy $$556.52M
Sell $$2.40B
Ratio1:4.31
% Change vs. Prior
Ratio +413.8%Value -53.3%
Consumer Defensive
Buys106
Sells549
Buy $$56.90M
Sell $$1.78B
Ratio1:31.22
% Change vs. Prior
Ratio +36.5%Value -77.4%
Communication Services
Buys177
Sells744
Buy $$58.61M
Sell $$973.91M
Ratio1:16.62
% Change vs. Prior
Ratio -53.6%Value -4.1%
Basic Materials
Buys119
Sells320
Buy $$172.28M
Sell $$796.30M
Ratio1:4.62
% Change vs. Prior
Ratio -4.2%Value +78.7%
Real Estate
Buys167
Sells458
Buy $$86.81M
Sell $$279.96M
Ratio1:3.23
% Change vs. Prior
Ratio +929.2%Value -83.6%
By Industry
Hardware, Equipment & Parts
Buys28
Sells632
Buy $$13.75B
Sell $$646.66M
Ratio21.26:1
% Change vs. Prior
Ratio +1257315.5%Value +832.9%
Medical - Instruments & Supplies
Buys46
Sells103
Buy $$18.63M
Sell $$7.66B
Ratio1:411.19
% Change vs. Prior
Ratio -98.9%Value +139.6%
Independent Power Producers
Buys0
Sells13
Buy $$0.00
Sell $$5.30B
RatioAll Sells
Oil & Gas Exploration & Production
Buys118
Sells248
Buy $$14.92M
Sell $$3.53B
Ratio1:236.58
Aerospace & Defense
Buys42
Sells610
Buy $$15.59M
Sell $$3.18B
Ratio1:204.22
% Change vs. Prior
Ratio -93.9%Value +125.9%
Semiconductors
Buys45
Sells1165
Buy $$2.34M
Sell $$2.69B
Ratio1:1150.70
% Change vs. Prior
Ratio -92.8%Value +79.5%
Biotechnology
Buys294
Sells3147
Buy $$466.13M
Sell $$2.12B
Ratio1:4.55
% Change vs. Prior
Ratio -61.2%Value -29.7%
Software - Infrastructure
Buys57
Sells1664
Buy $$40.79M
Sell $$1.98B
Ratio1:48.63
% Change vs. Prior
Ratio +174.0%Value -22.7%
Specialty Retail
Buys56
Sells545
Buy $$200.26M
Sell $$1.81B
Ratio1:9.03
Engineering & Construction
Buys11
Sells146
Buy $$2.69M
Sell $$2.00B
Ratio1:744.49
Medical - Healthcare Information Services
Buys24
Sells208
Buy $$30.73M
Sell $$1.76B
Ratio1:57.15
Renewable Utilities
Buys5
Sells24
Buy $$104.80K
Sell $$1.68B
Ratio1:16039.90
Software - Application
Buys119
Sells1603
Buy $$381.00M
Sell $$1.29B
Ratio1:3.38
% Change vs. Prior
Ratio +159.7%Value -36.5%
Asset Management
Buys807
Sells232
Buy $$256.06M
Sell $$1.02B
Ratio1:4.00
% Change vs. Prior
Ratio +97.9%Value -13.0%
Computer Hardware
Buys3
Sells578
Buy $$412.15K
Sell $$1.20B
Ratio1:2923.08
Transactions (21426)
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%
CytomX Therapeutics, Inc. (CTMX)
BELVIN MARCIA — SVP, Chief Scientific Officer
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
141
Price
$155.00
Total Value
$21.86K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%
SentinelOne, Inc. (S)
Weingarten Tomer — Director
Shares
38,864
Price
$14.47
Total Value
$562.35K
Shares Held After
1,007,277
% of Holdings
3.7%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
75
Price
$159.15
Total Value
$11.94K
Shares Held After
115,113
% of Holdings
0.1%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,375
Price
$158.36
Total Value
$217.75K
Shares Held After
115,188
% of Holdings
1.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
275
Price
$157.66
Total Value
$43.36K
Shares Held After
116,563
% of Holdings
0.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,575
Price
$156.33
Total Value
$246.21K
Shares Held After
116,838
% of Holdings
1.3%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,704
Price
$155.00
Total Value
$264.12K
Shares Held After
118,413
% of Holdings
1.4%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,484
Price
$153.91
Total Value
$228.40K
Shares Held After
120,117
% of Holdings
1.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,012
Price
$152.66
Total Value
$154.49K
Shares Held After
121,601
% of Holdings
0.8%
Accel Entertainment, Inc. (ACEL)
Rubenstein Andrew H. — Director
Shares
3,938
Price
$11.23
Total Value
$44.22K
Shares Held After
3,956,368
% of Holdings
0.1%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Pacira BioSciences, Inc. (PCRX)
Froimson Mark — Director
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%
Pacira BioSciences, Inc. (PCRX)
SLONIN JONATHAN — Chief Medical Officer
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,587
Price
$33.38
Total Value
$86.34K
Shares Held After
47,484
% of Holdings
5.2%
Showing 2101–2150 of 21426 transactions (page 43 of 429)